Interleukin-18 and Crohn’s Disease
- 15 January 2001
- journal article
- Published by S. Karger AG in Digestion
- Vol. 63 (Suppl. 1) , 37-42
- https://doi.org/10.1159/000051909
Abstract
The etiology and pathogenesis of inflammatory bowel disease remains an area under intense investigation. Crohn’s disease (CD) is characterized by a marked accumulation of activated Th1 type CD4+ T cells and macrophages in inflamed intestinal mucosa. IL-18 is a recently described cytokine that mainly exists in activated macrophages and shares biological activities with IL-12 in driving the development of Th1 type CD4+ T cells by inducing interferon-γ. To clarify the role of IL-18 in intestinal inflammation in CD, we assessed the functional role of IL-18 in regulating intestinal mucosal lymphocytes in human CD and murine CD model.Keywords
This publication has 8 references indexed in Scilit:
- A synthetic mimetic of CD4 is able to suppress disease in a rodent model of immune colitisEuropean Journal of Immunology, 1999
- Cloning of a Novel Receptor Subunit, AcPL, Required for Interleukin-18 SignalingJournal of Biological Chemistry, 1998
- Purification and Characterization of the Human Interleukin-18 ReceptorJournal of Biological Chemistry, 1997
- Characterization of anti-human interleukin-18 (IL-18)/interferon-γ-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISAJournal of Immunological Methods, 1997
- Tap: A Novel Cellular Protein That Interacts with Tip of Herpesvirus Saimiri and Induces Lymphocyte AggregationImmunity, 1997
- Preferential Activation of CD4+Vβ5.2/5.3+Intestinal Intraepithelial Lymphocytes in the Inflamed Lesions of Crohn's DiseaseClinical Immunology and Immunopathology, 1996
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.The Journal of Experimental Medicine, 1995
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995